Results 171 to 180 of about 282,352 (292)
Exploring the association of calbindin -D28K in renal dialysis with oral health: a comprehensive review. [PDF]
Jaber M +3 more
europepmc +1 more source
Case report of an arteriovenous graft for renal dialysis, with multiple complications treated successfully over 5 years. [PDF]
Mansoor T, Healy D, Moneley D.
europepmc +1 more source
Abstract End‐ischemic viability testing by normothermic machine perfusion (NMP) represents an effective strategy to recover liver grafts having initially been discarded for liver transplantation (LT). However, its results in the setting of significant (≥30%) macrovesicular steatosis (MaS) have not been specifically assessed.
Damiano Patrono +8 more
wiley +1 more source
Mid‐term survival in patients awaiting heart and kidney transplantation with Impella 5.5 support
Abstract Background Patients with end‐stage heart failure and chronic kidney disease requiring dual‐organ transplantation (DOT) face significant challenges in utilizing durable mechanical circulatory support due to the risks associated with renal replacement therapies (RRTs) and multi‐organ failure.
Smruti Desai +12 more
wiley +1 more source
The utilization of renal dialysis: a comprehensive study in Saudi Arabia. [PDF]
Alghamdi LS, Alonazi W.
europepmc +1 more source
Correlates of symptom burden in renal dialysis patients: a systematic review and meta-analysis. [PDF]
Lu Y +6 more
europepmc +1 more source
Impact of empagliflozin in patients with and without T2D or CKD in the EMPACT‐MI trial. Baseline characteristics, HF outcomes and subgroup analysis of efficacy endpoints are shown. # Hazard ratios estimated via Cox proportional hazard model (unless indicated otherwise). ^ Rate ratios via negative binomial regression.
Francesco Fioretti +23 more
wiley +1 more source
Elranatamab treatment in a multiple myeloma patient undergoing renal dialysis. [PDF]
Van de Wyngaert Z +7 more
europepmc +1 more source
Abstract Aims The EMAIL‐HF trial aims to evaluate whether a digital guideline implementation strategy can increase and accelerate initiation of sodium‐glucose co‐transporter 2 (SGLT2) inhibitors in patients with heart failure (HF). Methods and results EMAIL‐HF is a pragmatic, registry‐based, randomized controlled trial including patients with a ...
Mariam Elmegaard +21 more
wiley +1 more source

